Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nasal High-Flow Therapy to Treat COPD Exacerbations: a Matter of Monitoring and Controlling Settings?

NCT03564236 is registered in ClinicalTrials.gov with Marieke Duiverman as lead sponsor.

NCT NCT03564236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03564236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nasal High-Flow Therapy to Treat COPD Exacerbations: a Matter of Monitoring and Controlling Settings?
Lead sponsor
Marieke Duiverman
Phase
Not applicable
Overall status
Recruiting
Start date
October 1, 2018
Completion date
December 30, 2025
Enrollment
136 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

copd exacerbation